Stocks & ETFs Screener: 98 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
963B | 82.1% | 76.7% | 58.9% | 52.6 | 22.5% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Devices, Lenses |
499B | 73.9% | 63.0% | 65.2% | 20.0 | 28.1% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
285B | 79.5% | 46.7% | 55.7% | 30.5 | 20.5% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
284B | 86.4% | 51.4% | 44.0% | 30.6 | 6.02% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular, Oncology |
265B | 91.8% | 61.5% | 70.0% | 18.9 | 26.5% |
| MRK Merck |
Pharmaceuticals
Oncology Vaccines Antimicrobials |
263B | 83.0% | 68.0% | 39.7% | 13.9 | -4.60% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity, Growth, Blood |
226B | 89.4% | 46.2% | -49.0% | 13.9 | -45.5% |
| PFE Pfizer |
Pharmaceuticals
Medicines, Vaccines, Biosimilars |
142B | 57.6% | 78.4% | -8.79% | 14.5 | -13.5% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Immunology, Oncology |
118B | 61.7% | 59.8% | 8.88% | 15.8 | -11.8% |
| SAN Sanofi |
Pharmaceuticals
Vaccines, Oncology, Neurology |
116B | 75.3% | 69.8% | -18.6% | 15.6 | -21.8% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Immunotherapy |
109B | 73.4% | 81.4% | -7.0% | 18.0 | -14.7% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
99.2B | 76.9% | 24.1% | 76.8% | 13.7 | 31.3% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
98.2B | 80.1% | 34.9% | 52.1% | 13.7 | 15.3% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Filtration, Antibodies |
62.4B | 61.9% | 65.8% | -25.6% | 18.0 | -25.7% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
56.0B | 83.4% | 74.1% | -53.5% | 21.3 | -33.8% |
| TAK Takeda |
Pharmaceuticals
Oncology, Gastroenterology |
52.1B | 62.5% | 37.3% | 54.4% | 224 | 5.82% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
42.6B | 46.2% | 1.77% | 37.2% | - | 66.8% |
| TEVA Teva Pharma |
Pharmaceuticals
Generics, Respiratory, CNS |
35.8B | 53.1% | 17.4% | 65.0% | 51.2 | 26.5% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Biopharma, Investments |
22.7B | 56.4% | 60.7% | 71.9% | 22.2 | 33.3% |
| VTRS Viatris |
Pharmaceuticals
Prescription, Generic, Biosimilar |
14.4B | 28.9% | 54.0% | 23.7% | - | -5.63% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.6B | 76.5% | 11.8% | -14.1% | 17.8 | -22.1% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Neuroscience, Rare |
11.6B | 87.4% | 60.5% | 8.58% | 22.3 | -12.9% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
11.2B | 41.8% | - | 64.1% | 322 | 62.7% |
| JAZZ Jazz |
Pharmaceuticals
Xywav, Xyrem, Epidiolex, Rylaze |
10.3B | 51.2% | - | 48.2% | - | 22.4% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Wake-Promoting |
9.21B | 32.4% | - | 67.0% | - | 80.8% |
| TERN Terns |
Pharmaceuticals
Kinase Inhibitor, Thyroid Agonist |
4.39B | 34.6% | - | 62.2% | - | 505% |
| CORT Corcept |
Pharmaceuticals
Hyperglycemia, Cushings |
4.03B | 67.0% | - | -10.9% | 43.9 | -36.3% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
3.96B | 60.9% | - | 72.3% | - | 40.3% |
| TARS Tarsus |
Pharmaceuticals
Eye Therapy, Mite Blepharitis |
3.48B | 36.6% | - | 57.3% | - | 23.8% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.45B | 85.5% | 58.9% | 34.1% | 22.2 | -5.31% |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic, Diaper, Throat, Eye |
3.01B | 63.7% | 1.0% | -42.4% | 15.2 | -29.2% |
| LQDA Liquidia |
Pharmaceuticals
Dry Powder Injectable Liposomal |
3.00B | 27.3% | - | 63.5% | - | 122% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, GalNAc-Conjugated |
2.96B | 35.9% | - | 27.4% | - | 5.44% |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.85B | 45.9% | - | 64.7% | - | 15.0% |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.67B | 51.3% | 3.14% | -17.4% | 7.43 | -20.4% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dexamethasone, Axitinib, Travoprost |
2.59B | 31.9% | - | 40.2% | - | 14.7% |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, BP1.15205 |
2.17B | 91.9% | - | 9.90% | 11.9 | -6.68% |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.12B | 73.4% | 29.7% | 6.44% | 16.9 | -14.3% |
| AVDL Avadel |
Pharmaceuticals
Sodium Oxybate, Narcolepsy |
2.11B | 64.0% | - | 57.7% | - | 73.4% |
| MAZE Maze Therapeutics |
Pharmaceuticals
MZE829, MZE782, MZE001, Renal |
1.99B | 24.7% | - | 86.9% | - | 118% |
| PRGO Perrigo |
Pharmaceuticals
OTC, Vitamins, Infant Formula |
1.91B | 46.5% | 77.5% | -65.5% | - | -50.1% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
1.88B | 56.7% | 13.0% | -60.6% | 3.79 | -58.7% |
| HROW Harrow Health |
Pharmaceuticals
Antibiotic, Steroid |
1.81B | 43.9% | - | 68.3% | - | 19.6% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
1.76B | 68.7% | - | 44.2% | 49.0 | 23.7% |
| INVA Innoviva |
Pharmaceuticals
Inhaled Combo, Vasoconstrictor |
1.66B | 80.7% | 1.25% | 34.4% | 13.4 | -1.53% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Chronic Cough, Nalbuphine |
1.61B | 37.3% | - | 62.6% | - | 137% |
| PAHC Phibro Animal |
Pharmaceuticals
Antibacterials, Vaccines |
1.55B | 61.6% | 36.4% | 55.4% | 22.9 | 58.4% |
| EVT Evotec SE |
Pharmaceuticals
Oncology, Autoimmune, Metabolic |
1.49B | 22.2% | - | -67.2% | - | -44.3% |
| EYPT Eyepoint |
Pharmaceuticals
Sustained Drug Implant, VEGF |
1.45B | 29.0% | - | 74.8% | - | 73.5% |
| COLL Collegium |
Pharmaceuticals
Stimulant, Buccal, Opioid |
1.44B | 78.9% | - | 52.2% | 27.9 | 37.0% |
| RAPP Rapport |
Pharmaceuticals
Epilepsy, Neuropathic Pain |
1.34B | 31.5% | - | 59.0% | - | 34.6% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, AMX0035, AMX0114, GLP-1 |
1.25B | 30.2% | - | 20.4% | - | 151% |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
1.25B | 46.7% | - | 55.4% | - | 9.10% |
| AMPH Amphastar P |
Pharmaceuticals
Injectable, Inhalation |
1.25B | 76.4% | - | -13.6% | 11.9 | -35.7% |
| XERS Xeris |
Pharmaceuticals
Glucagon, Cortisol, Paralysis |
1.21B | 63.4% | - | 41.4% | - | 78.8% |
| PHAT Phathom |
Pharmaceuticals
Tablet, Antibiotic, Proton-Pump |
1.18B | 66.3% | - | 61.1% | - | 77.8% |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
1.16B | 42.0% | - | 55.1% | - | 30.2% |
| PCRX Pacira BioSciences |
Pharmaceuticals
EXPAREL, ZILRETTA, Iovera |
1.10B | 62.7% | - | -2.14% | 52.0 | 13.1% |
| TLRY Tilray |
Pharmaceuticals
Cannabis, Beverages, Wellness |
1.05B | 47.7% | - | -39.9% | - | -40.2% |
| CRON Cronos |
Pharmaceuticals
Dried Flower, Pre-Roll, Oil |
1.03B | 47.0% | - | 46.8% | 24.6 | 14.6% |
| CRMD CorMedix |
Pharmaceuticals
Antimicrobial, Catheter, Solution |
983M | 91.8% | - | 59.9% | 5.65 | 32.1% |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Norepinephrine |
948M | 51.0% | - | 79.7% | 32.8 | 70.1% |
| ELVN Enliven |
Pharmaceuticals
Kinase Inhibitor, HER2 Inhibitor |
922M | 32.4% | - | -45.8% | - | -44.4% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Autoimmune, Inflammation, Cancer |
869M | 32.5% | - | 50.6% | - | 113% |
| ARVN Arvinas |
Pharmaceuticals
Protac, Degrader, Breast |
842M | 39.9% | - | -7.29% | - | -50.4% |
| AQST Aquestive |
Pharmaceuticals
Buccal Film, Sublingual Film, Oral |
788M | 59.5% | - | 64.1% | - | 68.4% |
| NBY NovaBay |
Pharmaceuticals
Wound Cleanser, Hypochlorous Acid |
781M | 51.5% | 34.4% | 32.1% | 1.20 | 1,095% |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
746M | 23.1% | - | 47.9% | - | 91.2% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735 |
644M | 35.3% | - | 52.1% | - | 199% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Antidepressant, Cognitive |
573M | 44.2% | - | 50.3% | - | 229% |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
460M | 46.6% | - | 62.1% | 0.94 | 105% |
| ETON Eton |
Pharmaceuticals
Adrenal, Wilson, PKU, Tyrosinemia |
453M | 57.0% | - | 19.5% | - | 15.2% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox Treatment |
449M | 79.6% | 80.3% | 17.7% | 6.09 | -6.81% |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
438M | 17.5% | - | -48.5% | - | -64.9% |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
436M | 28.9% | - | -51.1% | - | -47.4% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Alcohol, Retail, Flower |
427M | 50.9% | - | -38.2% | - | -20.7% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
416M | 30.5% | - | -21.9% | - | -31.0% |
| RLMD Relmada |
Pharmaceuticals
Gemcitabine, Docetaxel |
331M | 45.2% | - | 78.9% | - | 755% |
| ACRS Aclaris |
Pharmaceuticals
JAK Inhibitor, TSLP Antibody |
312M | 32.8% | - | 5.29% | - | -1.95% |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Small-Molecule |
286M | 25.5% | - | -15.3% | - | -18.7% |
| NMRA Neumora |
Pharmaceuticals
Depression, Agitation, Alzheimer |
282M | 49.5% | - | -35.7% | - | -42.4% |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
272M | 30.4% | - | 0.06% | - | -11.8% |
| ACB Aurora Cannabis |
Pharmaceuticals
Cannabis, Oils, Capsules, Edibles |
246M | 67.1% | - | -41.5% | - | -19.8% |
| MDWD Mediwound |
Pharmaceuticals
Burn Debridement, Chronic Wound |
241M | 20.3% | - | 14.8% | - | -10.6% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading Platform, Payment Gateway |
239M | 27.8% | 1.0% | -62.2% | - | -82.2% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis, Flower, Pre-Rolls |
229M | 20.8% | - | 8.38% | - | -11.3% |
| MIST Milestone |
Pharmaceuticals
Etripamil, Calcium Channel |
172M | 24.5% | - | -11.6% | - | -19.4% |
| SAVA Cassava Sciences |
Pharmaceuticals
Simufilam, SavaDx |
142M | 34.6% | 1.0% | -47.2% | - | -38.8% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Vaccine, Lymph Node, Preclinical |
139M | 45.7% | - | -1.48% | - | 19.6% |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Diseases |
139M | 40.0% | - | 35.7% | - | 26.8% |
| CNTX Context |
Pharmaceuticals
Anti-Claudin6 Bispecific, T-Cell |
135M | 29.8% | - | 56.3% | - | 14.1% |
| VRCA Verrica |
Pharmaceuticals
Cantharidin, VP-102, VP-315 |
133M | 26.1% | - | 17.4% | - | 6.12% |
| SLGL Sol Gel |
Pharmaceuticals
Acne Cream, Rosacea Cream |
99.1M | 28.6% | - | 36.2% | - | 263% |
| SCLX Scilex Holding |
Pharmaceuticals
Lidocaine, Migraine, Anti-Gout |
96.2M | 67.5% | - | -43.5% | - | -36.8% |
| EVOK Evoke Pharma |
Pharmaceuticals
Nasal Spray, Diabetic Gastroparesis |
19.0M | 30.9% | - | 48.9% | - | 315% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual Tablets, Aspirin |
18.3M | 39.1% | - | -70.2% | - | -99.0% |
| KALA Kala |
Pharmaceuticals
KPI-012, KPI-014, Eye Therapy |
6.97M | 25.4% | - | -66.3% | - | -92.9% |
| YCBD cbdMD |
Pharmaceuticals
CBD Tinctures, Gummies, Topicals |
6.58M | 15.4% | - | -41.6% | 1.45 | -77.6% |